Dr. NeSmith is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2401 W Belvedere Ave
Baltimore, MD 21215Phone+1 843-792-2731
Education & Training
Medical University of South CarolinaResidency, Internal Medicine, 2021 - 2024
University of Alabama at BirminghamMPH, 2019 - 2020
University of Alabama School of MedicineClass of 2020, MD
Certifications & Licensure
MD State Medical License 2023 - 2025
PA State Medical License 2023 - 2024
SC State Medical License 2021 - 2024
Publications & Presentations
PubMed
- 20 citationsShort-term effect of elexacaftor-tezacaftor-ivacaftor on lung function and transplant planning in cystic fibrosis patients with advanced lung disease.Bermingham B, A. Rueschhoff, G. Ratti, Andrew NeSmith, Dana L. Goodwin
Journal of Cystic Fibrosis. 2021-06-21 - 45 citationsElexacafator/tezacaftor/ivacaftor resolves subfertility in females with CF: A two center case series.Kate E. O'Connor, Dana L. Goodwin, Andrew NeSmith, Bryan Garcia, Christina Mingora
Journal of Cystic Fibrosis. 2021-05-01 - 27 citationsFavorable Clinician Acceptability of Telehealth as Part of the Cystic Fibrosis Care Model during the COVID-19 Pandemic.Ryan C Perkins, Jaclyn Davis, Andrew NeSmith, Julianna Bailey, Michael R. Powers
Annals of the American Thoracic Society. 2021-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
